close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

EKTA.B

59.85

+2.22%↑

EKTA.B

59.85

+2.22%↑

EKTA.B

59.85

+2.22%↑

EKTA.B

59.85

+2.22%↑

EKTA.B

59.85

+2.22%↑

Kodu・Aktsiate loetelu・BioArctic AB
Search

BioArctic AB

Suletud

330.4 -0.48

Hinna uuendus 9. jaan 2026, 16:24 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

329.8

Max

330.8

Põhinäitajad

By Trading Economics

Sissetulek

-208M

-29M

Müük

-259M

133M

P/E

Sektori keskmine

27.398

87.826

Aktsiakasum

-0.98

Kasumimarginaal

-21.576

Töötajad

122

EBITDA

-206M

-18M

Turustatistika

By TradingEconomics

Turukapital

1.5B

27B

Eelmine avamishind

330.88

Eelmine sulgemishind

330.4

BioArctic AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. jaan 2026, 00:16 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Drops Merger With JenaValve

DJ

Loe

10. jaan 2026, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Copper Is the Prize in Mining Megadeals -- WSJ

DJ

Loe

10. jaan 2026, 09:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

10. jaan 2026, 09:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

DJ

Loe

10. jaan 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

10. jaan 2026, 09:00 UTC

Tulu

Big Banks Expected to Post Higher Profits as Shares Surge -- Barrons.com

DJ

Loe

9. jaan 2026, 22:18 UTC

Market Talk

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

DJ

Loe

9. jaan 2026, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Loe

9. jaan 2026, 21:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

DJ

Loe

9. jaan 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

9. jaan 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

9. jaan 2026, 21:43 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

DJ

Loe

9. jaan 2026, 20:39 UTC

Market Talk

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

DJ

Loe

9. jaan 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

DJ

Loe

9. jaan 2026, 20:36 UTC

Omandamised, ülevõtmised, äriostud

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

DJ

Loe

9. jaan 2026, 20:30 UTC

Market Talk

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

DJ

Loe

9. jaan 2026, 20:15 UTC

Market Talk

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

DJ

Loe

9. jaan 2026, 20:07 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

9. jaan 2026, 20:07 UTC

Market Talk

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

DJ

Loe

9. jaan 2026, 19:58 UTC

Omandamised, ülevõtmised, äriostud

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

DJ

Loe

9. jaan 2026, 19:42 UTC

Market Talk

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

DJ

Loe

9. jaan 2026, 19:38 UTC

Omandamised, ülevõtmised, äriostud

Wolters Kluwer Acquires StandardFusion >WTKWY

DJ

Loe

9. jaan 2026, 19:31 UTC

Tulu

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

DJ

Loe

9. jaan 2026, 19:28 UTC

Tulu

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

DJ

Loe

9. jaan 2026, 18:30 UTC

Market Talk

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

DJ

Loe

9. jaan 2026, 18:23 UTC

Market Talk

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

DJ

Loe

9. jaan 2026, 17:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

DJ

Loe

9. jaan 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

9. jaan 2026, 17:19 UTC

Market Talk

Energy Prices Not Seen Supporting More Drilling -- Market Talk

DJ

Loe

9. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

BioArctic AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.

Muud aktsiad sektorist

EKTA.B

Elekta AB

59.85

↑ +2.22%
help-icon Live chat